Ropack primed for Stickpack container; Labtec plant handles transdermal patches, oral films;

> Canadian packager Ropack has flipped the switch on a $9 million, 15,000-square-foot production suite for solid oral dosage forms in Stickpacks--tube-shaped packs the size of a stick of gum. Item

> Labtec has opened a GMP-compliant manufacturing plant for transdermal patches and oral films in Hamburg. Labtec release

> India continues efforts to get its pharma house in order with the first pharmaceuticals census of India by the National Pharmaceutical Pricing Authority. Story

> Lufthansa Cargo has certified Hyderabad International Airport as one of its key cargo hubs for temperature-sensitive pharmaceuticals. Article

> According to the FDA's listing of drugs in short supply, Spectrum Pharmaceuticals has increased production of Fusilev 50-mg vials and is continuing to release supplies as they become available. Listing

> Congress is querying URL Pharma over its pricing of gout treatment Colcrys, based on a long-used API, for which the drugmaker won market exclusivity under FDA's crackdown on drugs lacking official approval. News

> ClorDiSys Solutions of Lebanon, NJ, has launched a chlorine-dioxide gas decontamination service for pharma  manufacturing plants. Release

> Detroit-based contract drug developer and manufacturer Ash Stevens has been named among the fastest growing inner-city companies in the U.S. Release

Suggested Articles

Recipharm has been building its capabilities in sterile injectable and inhalation drugs. Now it is buying a CDMO that manufactures devices for both.

The FDA has slapped the parent of Dollar Tree stores with a warning letter saying some CMOs that made its OTC products were among the world's worst.

GSK expects Shingrix supplies to rise slightly in 2020, but the real "step change" will come in 2024 with a brand-new manufacturing facility.